Book contents
- Observation Medicine
- Observation Medicine
- Copyright page
- Contents
- Advance Praise
- About the Editors
- Contributors
- Foreword: Onward and Upward
- Preface
- Part I Administration: Key Concepts of Observation Medicine, and Developing and Maintaining an Observation Unit
- Part II Observation Medicine: Clinical Setting and Education
- Part III New Developments in Observation Medicine
- Part IV Clinical
- Subpart IVA Clinical – Cardiac
- Subpart IVB Clinical – Respiratory
- Subpart IVC Clinical – Vascular
- Chapter 31 Deep Vein Thrombosis (DVT)
- Chapter 32 Acute Pulmonary Embolism (PE)
- Chapter 33 Anticoagulants
- Subpart IVD Clinical – Neurologic
- Subpart IVE Clinical – Metabolic, Endocrine
- Subpart IVF Clinical – Hematologic
- Subpart IVG Clinical – Infections
- Subpart IVH Clinical – Gastrointestinal
- Subpart IVI Clinical – Genitourinary
- Subpart IVJ Clinical – Obstetrics and Gynecology
- Subpart IVK Clinical – Pediatrics and Geriatrics
- Subpart IVL Clinical – Surgical Evaluation
- Subpart IVM Clinical – Pain Management and Musculoskeletal
- Subpart IVN Clinical – Trauma
- Subpart IVO Clinical – Toxicology
- Subpart IVP Clinical – Psychosocial
- Subpart IVQ Clinical – Disasters
- Part V Financial
- Part VI International
- Part VII Evidence Basis for Observation Medicine
- Part VIII Clinical Protocols
- Part IX Administrative Policies
- Part X Order Sets
- Prologue
- Index
- References
Chapter 31 - Deep Vein Thrombosis (DVT)
from Subpart IVC - Clinical – Vascular
Published online by Cambridge University Press: 31 March 2017
Edited by
Book contents
- Observation Medicine
- Observation Medicine
- Copyright page
- Contents
- Advance Praise
- About the Editors
- Contributors
- Foreword: Onward and Upward
- Preface
- Part I Administration: Key Concepts of Observation Medicine, and Developing and Maintaining an Observation Unit
- Part II Observation Medicine: Clinical Setting and Education
- Part III New Developments in Observation Medicine
- Part IV Clinical
- Subpart IVA Clinical – Cardiac
- Subpart IVB Clinical – Respiratory
- Subpart IVC Clinical – Vascular
- Chapter 31 Deep Vein Thrombosis (DVT)
- Chapter 32 Acute Pulmonary Embolism (PE)
- Chapter 33 Anticoagulants
- Subpart IVD Clinical – Neurologic
- Subpart IVE Clinical – Metabolic, Endocrine
- Subpart IVF Clinical – Hematologic
- Subpart IVG Clinical – Infections
- Subpart IVH Clinical – Gastrointestinal
- Subpart IVI Clinical – Genitourinary
- Subpart IVJ Clinical – Obstetrics and Gynecology
- Subpart IVK Clinical – Pediatrics and Geriatrics
- Subpart IVL Clinical – Surgical Evaluation
- Subpart IVM Clinical – Pain Management and Musculoskeletal
- Subpart IVN Clinical – Trauma
- Subpart IVO Clinical – Toxicology
- Subpart IVP Clinical – Psychosocial
- Subpart IVQ Clinical – Disasters
- Part V Financial
- Part VI International
- Part VII Evidence Basis for Observation Medicine
- Part VIII Clinical Protocols
- Part IX Administrative Policies
- Part X Order Sets
- Prologue
- Index
- References
Summary
A summary is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
- Type
- Chapter
- Information
- Observation MedicinePrinciples and Protocols, pp. 159 - 164Publisher: Cambridge University PressPrint publication year: 2017
References
White, R. The epidemiology of venous thromboembolism. Circulation. 2003; 107(23 suppl 1):I 4–8.CrossRefGoogle ScholarPubMed
Beckman, MG, Hooper, WC, Critchley, SE, et al. Venous thromboembolism: a public health concern. AM J Prev Med. 2010 Apr; 38 (4Suppl):S495–501.CrossRefGoogle ScholarPubMed
Spyropoulos, AC, Lin, J. Direct medical costs of venous thromboembolism and subsequent hospital readmission rates: an administrative claims analysis from 30 managed care organizations. J Manag Care Pharm. 2007 Jul-Aug; 13(6): 475– 486.Google ScholarPubMed
Hirsh, J, Guyatt, G, Albers, GW, et al. American College of Chest Physicians. Antithrombotic and thrombolytic therapy: American College of Chest Physicians evidence based clinical practice guidelines, 9th ed. Chest. 2008; 133(6 suppl): 110s–112s.CrossRefGoogle Scholar
Cushman, M, Tsai, AW, White, RH, et al. Deep vein thrombosis and pulmonary embolism in two cohorts: the longitudinal investigation of thromboembolism etiology. Am J Med. 2004 Jul 1; 117(1):19–25.CrossRefGoogle ScholarPubMed
Labropoulos, N, Jen, J, Jen, H, et al. Recurrent deep vein thrombosis: long-term incidence and natural history. Ann Surg. 2010 Apr; 251(4):749–753.CrossRefGoogle ScholarPubMed
Heit, JA. Venous thromboembolism: disease burden, outcomes and risk factors. J Thromb Haemost. 2005 Aug; 3(8):1611–1617.CrossRefGoogle ScholarPubMed
Prandoni, P, Lensing, AWA, Cogo, A, et al. Long-term outcomes after deep venous thrombosis of the lower extremities. Vasc Med. 1998; 3(1):57–60.CrossRefGoogle ScholarPubMed
Prandoni, P, Lensing, AWA, Cogo, A, et al. The long-term clinical course of acute deep venous thrombosis. Ann Intern Med. 1996; 125: 1–7.CrossRefGoogle ScholarPubMed
Kahn, SR. The post-thrombotic syndrome: the forgotten morbidity of deep venous thrombosis. J Thromb Thrombolysis. 2006 Feb; 21(1): 41–48.CrossRefGoogle ScholarPubMed
Roumen-Klappe, EM, Janssen, MC, Van Rossum, J, et al. Inflammation in deep vein thrombosis and the development of post-thrombotic syndrome: a prospective study. J Thromb Haemost. 2009 Apr; 7(4): 582–587.CrossRefGoogle ScholarPubMed
Anderson, FA Jr, Wheeler, HB, Goldberg, RJ, et al. A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism: the Worcester DVT Study. Arch Intern Med. 1991May; 151(5): 933–938.CrossRefGoogle ScholarPubMed
Hull, R, Hirsh, J, Sackett, DL, et al. Clinical validity of a negative venogram in patients with clinically suspected venous thrombosis. Circulation. 1981 Sep; 64(3):622–625.CrossRefGoogle ScholarPubMed
Wells, PS, Owen, C, Doucette, S, et al. Does this patient have deep vein thrombosis? JAMA. 2006 Jan 11; 295(2):199–207.CrossRefGoogle ScholarPubMed
Bates, SM, Jaeschke, R, Stevens, SM, et al. Diagnosis of DVT: Antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012 Feb 141(2 Suppl):e351S–418S.CrossRefGoogle ScholarPubMed
Prins, M, Lensing, AW, Bauersachs, R, et al. Oral rivaroxaban versus standard therapy for the treatment of symptomatic venous thromboembolism: a pooled analysis of the Einstein- DVT and PE randomized Studies. Thromb J. 2013 Sep 20:11(1).CrossRefGoogle ScholarPubMed
Burness, CB, Perry, C. Rivaroxaban: a review of its use in the treatment of deep vein thrombosis or pulmonary embolism and the prevention of recurrent venous thromboembolism. Drugs. 2014 Feb; 74(2):243–262.CrossRefGoogle ScholarPubMed
Einstein Investigators, Bauersachs, R, Berkowitz, SD, et al. Oral rivaroxaban for symptomatic venous thromboembolism. N Engl J Med. 2010 Dec23; 363(26): 2499–2510.Google ScholarPubMed
Einstein-PE Investigators, Buller, HR, Prins, MH, et al. Oral rivaroxaban for the treatment of symptomatic pulmonary embolism. N Engl J Med. 2012 Apr 5; 366(14): 1287–1297.Google ScholarPubMed
Kearon, C, Akl, EA, Ornealas, J, et al. Antithrombotic therapy for VTE disease: CHEST guideline and expert panel report. Chest. 2016 Feb1; 149(2):315–352.CrossRefGoogle ScholarPubMed
Kearon, C, Akl, EA, Comerota, AJ, et al. Antithrombotic therapy for VTE disease: antithrombotic therapy and prevention of thrombosis 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2012 Feb; 14(2 suppl):e419s–494s.Google Scholar
Hovanessian, HC. New-generation anticoagulants: the low molecular weight heparins. Ann Emerg Med. 1999 Dec; 34(6):768–779.CrossRefGoogle ScholarPubMed
Bossuyt, PM, Van den Belt, AG, Prins, MH. Out-of-hospital treatment of venous thrombosis: socioeconomic aspects and patients’ quality of life. Hemostasis. 1998; 28 Suppl 3:100–107.Google ScholarPubMed